title: Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine. Electronic address: eterpos@med.uoa.gr.
authors.forename: E
authors.initials: E
authors.lastname: Terpos
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine.
authors.forename: D
authors.initials: D
authors.lastname: Christoulas
authors.affiliation: Departments of Endocrinology.
authors.forename: P
authors.initials: P
authors.lastname: Kokkoris
authors.affiliation: Haematology, 251 General Air Force Hospital, Athens, Greece.
authors.forename: K
authors.initials: K
authors.lastname: Anargyrou
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Gavriatopoulou
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Migkou
authors.affiliation: Haematology, 251 General Air Force Hospital, Athens, Greece.
authors.forename: K
authors.initials: K
authors.lastname: Tsionos
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine.
authors.forename: M A
authors.initials: MA
authors.lastname: Dimopoulos
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000188:drug therapy; D011719:Pyrazines / Q000008:administration & dosage; D015996:Survival Rate; D016896:Treatment Outcome; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D001897:Boronic Acids; D004164:Diphosphonates; D007093:Imidazoles; D011719:Pyrazines; D000069286:Bortezomib; D000077211:Zoledronic Acid; D003907:Dexamethasone